Kawakami Mark has filed 4 insider transactions across 1 company since August 2024.
Most recent transaction: a grant/award of 12500 shares of Arcadia Biosciences, Inc. ($RKDA) on May 09, 2025.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 | Arcadia Biosciences, Inc. | $RKDA | Kawakami Mark | Chief Financial Officer | A | Stock Option (Right to Buy) | 12500 | $0.00 | 33,987.0000 | 1,367,040 | 58.17% | 0.91% |
| Feb. 3, 2025 | Arcadia Biosciences, Inc. | $RKDA | Kawakami Mark | Chief Financial Officer | P | Common Stock | 700 | $2.49 | 2,681.0000 | 0 | 35.34% | 0.00% |
| Aug. 19, 2024 | Arcadia Biosciences, Inc. | $RKDA | Kawakami Mark | Chief Financial Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 21,487.0000 | 0 | 1344.99% | 0.00% |
| Aug. 1, 2024 | Arcadia Biosciences, Inc. | $RKDA | Kawakami Mark | Chief Financial Officer | P | Common Stock | 700 | $2.06 | 1,981.0000 | 0 | 54.64% | 0.00% |